ReachMD

Episodes 1-10 of 10

• • 

    

    Joel L. Cohen, MD

    Peer

  • 

    

    Jason D. Bloom, MD

    Peer

  0

  

  RestartResume

  Neuromodulator Dosing for the Upper Face 

  Neuromodulator Dosing for the Upper Face 

  0.25 credits

• • 

    

    Joel L. Cohen, MD

    Peer

  • 

    

    Carolyn I. Jacob, MD, FAAD

    Peer

  8

  

  RestartResume

  Neuromodulator Dosing for Duration

  Neuromodulator Dosing for Duration

  0.25 credits

• • 

    

    Andrew Alexis, MD, MPH

    Peer

  • 

    

    Linda Stein Gold, MD

    Peer

  0

  

  RestartResume

  Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging Evidence to Improve Outcomes

  Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging Evidence to Improve Outcomes

  0.25 credits

• • 

    

    Jeffrey S. Weber, MD, PhD

    Peer

  5

  

  RestartResume

  Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma

  Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma

  0.25 credits

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Lawrence F. Eichenfield, MD

    Peer

  • 

    

    Linda Stein Gold, MD

    Peer

  3

  

  RestartResume

  Moderate-to-Severe Atopic Dermatitis: Expert Insights on Late-Breaking Data in Systemic Treatment

  Moderate-to-Severe Atopic Dermatitis: Expert Insights on Late-Breaking Data in Systemic Treatment

  0.25 credits

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Lawrence F. Eichenfield, MD

    Peer

  2

  

  RestartResume

  Late-Breaking Data in Moderate-to-Severe Atopic Dermatitis

  Late-Breaking Data in Moderate-to-Severe Atopic Dermatitis

  0.25 credits

• • 

    

    Peter A. Lio, MD

    Peer

  • 

    

    Eric Simpson, MD, MCR

    Peer

  • 

    

    Mark Boguniewicz, MD

    Peer

  12

  

  RestartResume

  Advances in the Management of Moderate-to-Severe Atopic Dermatitis

  Advances in the Management of Moderate-to-Severe Atopic Dermatitis

• • 

    

    Chrysalyne D. Schmults, MD, MSCE (Chair)

    Peer

  • 

    

    Omid Hamid, MD

    Peer

  • 

    

    Anokhi Jambusaria, MD, MSCE, FAAD

    Peer

  9

  

  RestartResume

  cSCC Patient Clinic

  cSCC Patient Clinic

• • 

    

    Chrysalyne D. Schmults, MD, MSCE (Chair)

    Peer

  • 

    

    Omid Hamid, MD

    Peer

  • 

    

    Anokhi Jambusaria, MD, MSCE, FAAD

    Peer

  11

  

  RestartResume

  Selecting the RIGHT Patient for Systemic Therapy in cSCC: A Care Team Forum

  Selecting the RIGHT Patient for Systemic Therapy in cSCC: A Care Team Forum

• • 

    

    Chrysalyne D. Schmults, MD, MSCE (Chair)

    Peer

  • 

    

    Omid Hamid, MD

    Peer

  • 

    

    Anokhi Jambusaria, MD, MSCE, FAAD

    Peer

  11

  

  RestartResume

  New Systemic Options for Managing cSCC: A Care Team Forum

  New Systemic Options for Managing cSCC: A Care Team Forum